Issues and Controversies in Nuclear Medicine

• You have access

  Introduction

  Johannes Czernin and Wolfgang A. Weber

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.111.097071
• You have access

  The Janus Project: The Remaking of Nuclear Medicine and Radiology

  Steven M. Larson

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 3S-9S; DOI: https://doi.org/10.2967/jnumed.110.085761
• You have access

  Nuclear Medicine at a Crossroads

  Heinrich R. Schelbert

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 10S-15S; DOI: https://doi.org/10.2967/jnumed.110.085639
• You have access

  Trends in Nuclear Medicine in Developing Countries

  Maurizio Dondi, Ravi Kashyap, Diana Paez, Thomas Pascual, John Zaknun, Fernando Mut Bastos and Yaroslav Pynda

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 16S-23S; DOI: https://doi.org/10.2967/jnumed.111.089193
• You have access

  Status of and Trends in Nuclear Medicine in the United States

  Dominique Delbeke and George M. Segall

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 24S-28S; DOI: https://doi.org/10.2967/jnumed.110.085688
• You have access

  Subjective Perception of Radiation Risk

  Lutz S. Freudenberg and Thomas Beyer

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 29S-35S; DOI: https://doi.org/10.2967/jnumed.110.085720
• You have access

  How Many PET Tracers Do We Need?

  Markus Schwaiger and Hans-Jürgen Wester

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 36S-41S; DOI: https://doi.org/10.2967/jnumed.110.085738
• You have access

  Radiopeptide Imaging and Therapy in Europe

  Valentina Ambrosini, Melpomeni Fani, Stefano Fanti, Flavio Forrer and Helmut R. Maecke

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 42S-55S; DOI: https://doi.org/10.2967/jnumed.110.085753
• You have access

  Radiopeptide Imaging and Therapy in the United States

  Michael M. Graham and Yusuf Menda

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 56S-63S; DOI: https://doi.org/10.2967/jnumed.110.085746
• You have access

  Doing More Harm than Good? Do Systematic Reviews of PET by Health Technology Assessment Agencies Provide an Appraisal of the Evidence That Is Closer to the Truth than the Primary Data Supporting Its Use?

  Robert E. Ware and Rodney J. Hicks

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 64S-73S; DOI: https://doi.org/10.2967/jnumed.110.086611
• You have access

  Is There Evidence for Evidence-Based Medical Imaging?

  Wolfgang A. Weber

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 74S-76S; DOI: https://doi.org/10.2967/jnumed.111.100222
• You have access

  Generating Evidence for Clinical Benefit of PET/CT in Diagnosing Cancer Patients

  Werner Vach, Poul Flemming Høilund-Carlsen, Oke Gerke and Wolfgang A. Weber

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 77S-85S; DOI: https://doi.org/10.2967/jnumed.110.085704
• You have access

  Contribution of Imaging to Cancer Care Costs

  Yang Yang and Johannes Czernin

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 86S-92S; DOI: https://doi.org/10.2967/jnumed.110.085621
• You have access

  Need for Standardization of ¹⁸F-FDG PET/CT for Treatment Response Assessments

  Ronald Boellaard

  Journal of Nuclear Medicine December 1, 2011, 52 (Supplement 2) 93S-100S; DOI: https://doi.org/10.2967/jnumed.110.085662